These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 22560143
1. Mycophenolate mofetil for the management of autoimmune bullous diseases. Eskin-Schwartz M, David M, Mimouni D. Immunol Allergy Clin North Am; 2012 May; 32(2):309-15, vii. PubMed ID: 22560143 [Abstract] [Full Text] [Related]
2. Mycophenolate mofetil for the management of autoimmune bullous diseases. Eskin-Schwartz M, David M, Mimouni D. Dermatol Clin; 2011 Oct; 29(4):555-9. PubMed ID: 21924997 [Abstract] [Full Text] [Related]
4. Treatment of refractory blistering autoimmune diseases with mycophenolic acid. Marzano AV, Dassoni F, Caputo R. J Dermatolog Treat; 2006 Oct; 17(6):370-6. PubMed ID: 17853312 [Abstract] [Full Text] [Related]
5. Mycophenolate mofetil in autoimmune and inflammatory skin disorders. Nousari HC, Sragovich A, Kimyai-Asadi A, Orlinsky D, Anhalt GJ. J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):265-8. PubMed ID: 10025760 [Abstract] [Full Text] [Related]
6. Mycophenolate mofetil and skin diseases. Hartmann M, Enk A. Lupus; 2005 Feb; 14 Suppl 1():s58-63. PubMed ID: 15803935 [Abstract] [Full Text] [Related]
7. Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies. Schiavo AL, Puca RV, Ruocco V, Ruocco E. Clin Dermatol; 2010 Feb; 28(3):337-43. PubMed ID: 20541689 [Abstract] [Full Text] [Related]
8. Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases. Grundmann-Kollmann M, Korting HC, Behrens S, Kaskel P, Leiter U, Krähn G, Kerscher M, Peter RU. J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):957-60. PubMed ID: 10365927 [Abstract] [Full Text] [Related]
15. Mycophenolate mofetil therapy for pediatric bullous pemphigoid. Seminario-Vidal L, Sami N, Miller J, Theos A. Dermatol Online J; 2015 Aug 15; 21(8):. PubMed ID: 26437160 [Abstract] [Full Text] [Related]
16. [Auto-immune blistering diseases: a unique expertise in clinical research]. Joly P. Ann Dermatol Venereol; 2011 Mar 15; 138(3):169-71. PubMed ID: 21397146 [No Abstract] [Full Text] [Related]
17. Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update. Czernik A, Toosi S, Bystryn JC, Grando SA. Autoimmunity; 2012 Feb 15; 45(1):111-8. PubMed ID: 21923613 [Abstract] [Full Text] [Related]
18. Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases? Iaccarino L, Rampudda M, Canova M, Della Libera S, Sarzi-Puttinic P, Doria A. Autoimmun Rev; 2007 Jan 15; 6(3):190-5. PubMed ID: 17289556 [Abstract] [Full Text] [Related]
19. Refractory linear IgA bullous dermatosis successfully treated with mycophenolate sodium. Marzano AV, Ramoni S, Spinelli D, Alessi E, Berti E. J Dermatolog Treat; 2008 Jan 15; 19(6):364-7. PubMed ID: 19016105 [Abstract] [Full Text] [Related]
20. Autoimmune bullous dermatoses in the elderly: diagnosis and management. Mutasim DF. Drugs Aging; 2003 Jan 15; 20(9):663-81. PubMed ID: 12831291 [Abstract] [Full Text] [Related] Page: [Next] [New Search]